ANIK · Anika Therapeutics, Inc.
$21.50
+0.33 (+1.56%)
At close · Aug 14
View the 10-Q filed Jul 29, 2026
Customer concentration
— top customer 53% of revenue
One customer — 53% of revenue (the three months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the six months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
Market Cap
$287.73M
Shares
13.38M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-07-29 | 2026-06-30 | |
| 8-K | 2026-07-29 | — | |
| 8-K | 2026-07-14 | 2026-07-10 | |
| 8-K | 2026-06-23 | 2026-06-18 | |
| 10-Q | 2026-04-30 | 2026-03-31 | |
| 8-K | 2026-04-29 | 2026-04-24 | |
| DEF 14A | 2026-04-28 | 2026-06-18 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-08 | 2026-01-07 | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-06-24 | 2025-06-20 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-28 | 2025-06-20 | |
| 8-K | 2025-04-10 | 2025-04-04 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-12 | — | |
| 8-K | 2025-03-11 | 2025-03-07 | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-11 | 2024-07-09 | |
| DEF 14A | 2024-06-11 | 2024-07-09 | |
| 8-K | 2024-05-28 | — | |
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-05-08 | 2024-05-02 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 10-K/A | 2024-04-26 | 2023-12-31 | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2024-03-13 | — | |
| 8-K | 2024-02-26 | 2024-02-24 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-09-21 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-21 | 2023-06-14 | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| DEF 14A | 2023-05-01 | 0001-01-01 | |
| 8-K | 2023-04-28 | 2023-04-24 | |
| 8-K | 2023-04-13 | — | |
| 10-K | 2023-03-16 | 2022-12-31 |
Showing 1–50 of 103 filings
Key facts
CIK
898437
CUSIP
035255108
13F (30d)
125 filings
124 filers
Visit website
Investor relations